Autoimmune Thrombocytopenia clinical trials

Explore recruiting autoimmune thrombocytopenia clinical trials.

Recruiting autoimmune thrombocytopenia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autoimmune Thrombocytopenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ARGX-113-1803: A Phase 3, Multicenter, Open-label, Long-term Trial to Evaluate the Safety and Efficacy of Efgartigimod (ARGX-113) 10 mg/kg Intravenous in Adult Patients With Primary Immune Thrombocytopenia

Italy, Czechia, Poland, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multi-center, open-label, single-arm study to evaluate the efficacy and safety of oral rilzabrutinib in adults with immune thrombocytopenia (ITP) who failed first-line treatment

France, Spain, Italy, Germany, Czechia, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

INCA000585-201 - A PHASE 2A, OPEN-LABEL, MULTI-CENTER STUDY OF TAFASITAMAB IN ADULT PARTICIPANTS WITH AUTOIMMUNE BLOOD CELL DISORDERS

Netherlands, Italy, Spain, France

Phase II and Phase III (Integrated) EU CTIS Study details

Autoimmune Thrombocytopenia trials by city

Autoimmune Thrombocytopenia in Toronto Autoimmune Thrombocytopenia in Vancouver Autoimmune Thrombocytopenia in Montreal Autoimmune Thrombocytopenia in Calgary Autoimmune Thrombocytopenia in Edmonton Autoimmune Thrombocytopenia in Ottawa Autoimmune Thrombocytopenia in Winnipeg Autoimmune Thrombocytopenia in Quebec City Autoimmune Thrombocytopenia in Hamilton Autoimmune Thrombocytopenia in Kitchener Autoimmune Thrombocytopenia in London Autoimmune Thrombocytopenia in Halifax Autoimmune Thrombocytopenia in New York Autoimmune Thrombocytopenia in Los Angeles Autoimmune Thrombocytopenia in Chicago Autoimmune Thrombocytopenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease